QTREX Quantum CFO sells 30,000 shares via plan

QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales totaling 30,000 Ordinary Shares that were received upon vesting of Restricted Share Units.

Accepted by SEC EDGAR 06/02/2026 - 04:01 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales totaling 30,000 Ordinary Shares that were received upon vesting of Restricted Share Units. The underlying shares were then sold under an existing Rule 10b5-1 trading plan, indicating the transactions were pre-scheduled.

The reported sales included 28,100 shares at $3.50 per share on May 31, 2026 and 1,900 shares at $3.51 per share on May 29, 2026. After these transactions, Yafit directly holds 870,000 Ordinary Shares, so the disposals represent a small portion of her overall position.

Insider Trade Summary

Net Seller: 30,000 shares

Net Sell 2 txns

Insider Tehila Yafit

Role Chief Financial Officer

Sold 30,000 shs ($105K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	28,100	$3.50	$98K
Sale	Ordinary Shares	1,900	$3.51	$7K

Holdings After Transaction: Ordinary Shares — 870,000 shares (Direct)

Footnotes (1)

1. F1. Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying Ordinary Shares received were then sold. The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan.

Key Figures

Shares sold on 2026-06-01: 28,100 shares at $3.50 Shares sold on 2026-05-29: 1,900 shares at $3.51 Total shares sold: 30,000 shares +1 more

4 metrics

Shares sold on 2026-06-01 28,100 shares at $3.50 Open-market sale of Ordinary Shares by CFO

Shares sold on 2026-05-29 1,900 shares at $3.51 Open-market sale of Ordinary Shares by CFO

Total shares sold 30,000 shares Net shares sold across reported transactions

Shares held after transactions 870,000 shares Direct Ordinary Share holdings of CFO after sales

Key Terms

Restricted Share Units ("RSUs"), Rule 10b5-1 plan, Ordinary Shares, open-market sale

4 terms

Restricted Share Units ("RSUs") financial

"Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan..."

Rule 10b5-1 plan regulatory

"The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

Ordinary Shares financial

"...one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying Ordinary Shares received were then sold."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions were reported for QTREX Quantum Ltd. (IINN)?

QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported selling 30,000 Ordinary Shares. The shares came from vested RSUs and were sold in open-market transactions under an existing Rule 10b5-1 trading plan at prices around $3.50 per share.

How many QTREX Quantum (IINN) shares did the CFO sell and at what prices?

Tehila Yafit sold 28,100 Ordinary Shares at $3.50 per share and 1,900 shares at $3.51 per share. These open-market sales totaled 30,000 shares and followed the vesting of Restricted Share Units under a company equity plan.

How many QTREX Quantum (IINN) shares does the CFO hold after the Form 4 trades?

After the reported sales, Chief Financial Officer Tehila Yafit directly holds 870,000 Ordinary Shares. This means the 30,000 shares sold represent only a small fraction of her overall equity position in QTREX Quantum Ltd.

Were the QTREX Quantum (IINN) insider sales made under a Rule 10b5-1 plan?

Yes. The footnote states the securities were sold pursuant to an existing Rule 10b5-1 trading plan. Such plans are pre-arranged trading programs that schedule share sales in advance, reducing the significance of short-term market timing for these transactions.

Did the QTREX Quantum (IINN) CFO’s share sales follow RSU vesting?

Yes. The filing explains that Restricted Share Units vested, each RSU converting into one Ordinary Share. The underlying Ordinary Shares received from this vesting were then sold, indicating the transactions were related to equity compensation rather than new open-market purchases.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tehila Yafit

(Last) (First) (Middle)

2 HA-TIDHAR ST.

(Street)

RA'ANANA 4366504

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QTREX Quantum Ltd. [ QTEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/29/2026		S		1,900(1)	D	$3.51	898,100	D
Ordinary Shares	06/01/2026		S		28,100(1)	D	$3.5	870,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying Ordinary Shares received were then sold. The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan.

	/s/ Yafit Tehila	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)